Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P287: Lipid peroxidation levels and antioxidant status in serum, plasma and saliva of patients with active and inactive Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Szczeklik K.1, Krzysciak W.2, Domagala-Rodacka R.3, Cibor D.*3, Mach T.3, Owczarek D.3

1Jagiellonian University Medical College, Integrated Dentistry, Cracow, Poland 2Jagiellonian University Medical College, Medical Diagnostics, Faculty of Pharmacy, Cracow, Poland 3Jagiellonian University Medical College, Gastroenterology, Hepatology and Infectious Diseases, Cracow, Poland

P288: Treating beyond symptoms in inflammatory bowel disease (IBD): the Kent IBD Nurse Experience with the Steroid assessment toolECCO '17 Barcelona
Year: 2017
Authors:

Scott G.*1, Lewis W.2, Roads N.1

1East Kent Hospitals University NHS Foundation Trust, Gastroenterology, Canterbury, United Kingdom 2Medway Maritime Hospital, Department of Gastroenterology, Gillingham, United Kingdom

P289: Outcome of endoscopic ally resected dysplasic lesions in ulcerative colitisECCO '17 Barcelona
Year: 2017
Authors:

Saoula H.*1, Boutaleb A.2, Mahiou H.2, Aissaoui M.2, Salah A.2, Belhocine K.3, Bounab N.3, Hamidouche D.2, Gamar L.3, Aissat Y.2, Zmiri Y.2, Mitiche A.2, Osmane R.2, Kecili L.3, Berkane S.3, Boucekkine T.3, Amir Z.c.4, Nakmouche M.2

1CHU of Bab El Oued, Epidemiology, Algiers, Algeria 2CHU of Bab El Oued, Gastroenterology, Algiers, Algeria 3CHU Mustapha, Gastroenterology, Algiers, Algeria 4CHU Mustapha, Pathology, Algiers, Algeria

P290: Evaluation of patients with retained patency capsuleECCO '17 Barcelona
Year: 2017
Authors:

Silva M., Cardoso H., Peixoto A., Marques M., Nunes A.C.-R., Lopes S., Magro F., Macedo G.

Centro Hospitalar São João, Department of Gastroenterology, Porto, Portugal

P291: Proteinase 3-antineutrophil cytoplasmic antibodies (PR3-ANCA) would be a predictive biomarker for the clinical course of ulcerative colitisECCO '17 Barcelona
Year: 2017
Authors:

Sono M., Yoshino T., Yazumi S.

Kitano Hospital, Division of Gastroenterology and Hepatology, Digestive Disease Center, Osaka, Japan

P292: Perianal disease: far beyond a simple feature of Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Xavier S.*1, Gonçalves T.1, Castro F.1, Magalhães J.1, Moreira M.1, Cotter J.1,2,3

1Hospital da Senhora da Oliveira, Gastroenterology, Guimarães, Portugal 2Life and Health Sciences Research Institute, School of Medicine, University of Minho, Braga, Portugal 3Life and Health Sciences Research Institute/3B's, PT Government Associate Laboratory, Braga, Portugal

P293: Histological risk factors to predict clinical relapse in ulcerative colitis in mucosal healingECCO '17 Barcelona
Year: 2017
Authors:

Ozaki R.*1, Kobayashi T.1, Saito E.1, Toyonaga T.1, Okabayashi S.1, Umeda S.1, Nakano M.1, Matsuoka K.1, Morinaga S.1, Hisamatsu T.2, Hibi T.1

1Kitasato University Kitasato Institute Hospital, Minato, Japan 2Kyorin University School of Medicine, Mitaka, Japan

P294: Iron-deficiency without anemia in Crohn's disease: what are the predictive factors of recovery?ECCO '17 Barcelona
Year: 2017
Authors:

Cúrdia Gonçalves T.*1, Monteiro S.1, Barbosa M.1, Moreira M.J.1, Cotter J.1,2,3

1Hospital da Senhora da Oliveira, Gastroenterology, Guimarães, Portugal 2University of Minho, Life and Health Sciences Research Institute, School of Medicine, Braga, Portugal 3ICVS/3B's, PT Government Associate Laboratory, Braga/Guimarães, Portugal

P295: Absence of mucosal healing in patients undergoing assessment of mucosal healing with a normal PUCAI score in pediatric ulcerative colitisECCO '17 Barcelona
Year: 2017
Authors:

Sarbagili-Shabat C.*1, Wardi J.2, Boaz M.3, Levine A.1

1Paediatric and Gastroenterology and Nutrition Unit, Wolfson Medical Center, Tel Aviv University, Holon, Israel 2Gastroenterology Unit, Wolfson Medical Center, Tel Aviv University, Holon, Israel 3Department of Nutrition Sciences, Ariel University; Epidemiology and Research Unit, E. Wolfson Medical Center, Holon, Israel

P296: Persistent symptoms, CRP elevation and treatment changes over time in Crohn's disease patients are associated with bowel damage progression as expressed by deterioration of Lemann Index scoreECCO '17 Barcelona
Year: 2017
Authors:

Zezos P.*1, Chawla T.P.2, Weizman A.V.1, Nguyen G.C.1, Narula N.1, Kabakchiev B.3, Milgrom R.3, Croitoru K.1, Steinhart A.H.1, Silverberg M.S.1

1Mount Sinai Hospital, University of Toronto, Division of Gastroenterology, Toronto, Canada 2University Health Network and Mount Sinai Hospital, University of Toronto, Joint Department of Medical Imaging, Toronto, Canada 3Mount Sinai Hospital, Samuel Lunenfeld Research Institute, Toronto, Canada

P297: Fecal calprotectin accurately predicts symptomatic relapse in children and adolescents with inflammatory bowel disease in clinical remissionECCO '17 Barcelona
Year: 2017
Authors:

Diederen K.*1, Hoekman D.1, Leek A.2, Wolters V.2, Benninga M.1, Hummel T.3, de Meij T.4, Koot B.1, Tabbers M.1, Benninga M.1, Kindermann A.1

1Department of Pediatric Gastroenterology and Nutrition, Academic Medical Center, Amsterdam, Netherlands 2Department of Pediatric Gastroenterology, University Medical Center Utrecht, Utrecht, Netherlands 3Department of Pediatrics, Medisch Spectrum Twente, Enschede, Netherlands 4Department of Pediatric Gastroenterology, VU University Medical Center, Amsterdam, Netherlands

P298: Comparison between clinical and patient-reported symptoms among Crohn's disease and ulcerative colitis patientsECCO '17 Barcelona
Year: 2017
Authors:

Pittet V.*1, Maillard M.H.2, Rogler G.3, Michetti P.4

1Institute of Social & Preventive Medicine, Healthcare Evaluation Unit, Lausanne, Switzerland 2Lausanne University Hospital, Department of Gastroenterology & Hepatology, Lausanne, Switzerland 3University of Zurich, Gastroenterology and Hepatology, Zurich, Switzerland 4Clinique La Source-Beaulieu, Crohn and Colitis Center, Lausanne, Switzerland

P299: Identification of a prognostic biomarker able to predict ulcerative colitis patients that will not respond to standard therapyECCO '17 Barcelona
Year: 2017
Authors:

Pereira M.1, Carvalho S.1, Azevedo L.2, Albergaria A.1, Lima J.1, Reis C.3, Pedroto I.4, Maia L.4, Marcos-Pinto R.4, Lago P.4, Pinho S.S.*1

1IPATIMUP/i3S, University of Porto, Porto, Portugal 2University of Porto, Faculty of Medicine, Department of Health Information and Decision Sciences, Porto, Portugal 3IPATIMUP/i3S, University of Porto, Glycobiology in Cancer, Porto, Portugal 4Porto Centre Hospital, Hospital Santo Antόnio, Gastrenterology department, Porto, Portugal

P300: Illness perceptions and coping with health-related quality of life in patients with inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Cohen I.*1, Benyamini Y.2, Tulchinsky H.3, Dotan I.1

1Tel Aviv Sourasky Medical Center, affiliated to Sackler Faculty of Medicine, Tel Aviv University, Department of Gastroenterology and Liver Diseases, Tel-Aviv, Israel 2Tel Aviv University, Bob Shapell School of Social Work, Tel-Aviv, Israel 3Tel Aviv Sourasky Medical Center, affiliated to Sackler Faculty of Medicine, Proctology Unit, Department of Surgery, Tel-Aviv, Israel

P301: Non-familial small bowel carcinomas in Crohn's disease: clinico-pathological, molecular and prognostic featuresECCO '17 Barcelona
Year: 2017
Authors:

Di Sabatino A.*1, Vanoli A.2, Furlan D.3, Giuffrida P.1, Klersy C.4, Grillo F.5, Fiocca R.5, Mescoli C.6, Rugge M.6, Nesi G.7, Fociani P.8, Sampietro G.9, Ardizzone S.10, Luinetti O.2, Calabrò A.11, Tonelli F.7, Volta U.12, Santini D.13, Caio G.12, Elli L.14, Ferrero S.15, Latella G.16, Ciardi A.17, Solina G.18, Rizzo A.18, Ciacci C.19, D'Armiento F.P.20, Salemme M.21, Villanacci V.21, Cannizzaro R.22, Canzonieri V.23, Reggiani Bonetti L.24, Biancone L.25, Monteleone G.25, Orlandi A.25, Santeusanio G.26, Macciomei M.C.26, D'Incà R.6, Perfetti V.27, Sandri G.28, Silano M.29, Florena A.M.30, Giannone A.G.30, Papi C.31, Coppola L.31, Usai P.32, Maccioni A.33, Astegiano M.34, Migliora P.35, Manca R.36, Martino M.37, Trapani D.3, Cerutti R.3, Alberizzi P.36, Riboni R.36, Sessa F.3, Paulli M.36, Solcia E.2, Corazza G.R.1

1Fondazione IRCCS Policlinico San Matteo, University of Pavia, First Department of Medicine, Pavia, Italy 2Fondazione IRCCS Policlinico San Matteo, University of Pavia, Department of Molecular Medicine, Pavia, Italy 3University of Insubria, Department of Surgical and Morphological Sciences, Varese, Italy 4University of Pavia, Biometry and Statistics Service, San Matteo Hospital, Pavia, Italy 5Azienda Ospedaliera Universitaria San Martino, Genova, Italy 6Azienda Ospedaliera di Padova, Padova, Italy 7Azienda Ospedaliera Universitaria Careggi, Firenze, Italy 8Luigi Sacco University Hospital, Chair of Pathology, Milan, Italy 9Luigi Sacco University Hospital, Surgery Division, Department of Clinical Sciences, Milan, Italy 10Luigi Sacco University Hospital, Gastroenterology Unit, Department of Biomedical and Clinical Sciences, Milan, Italy 11University of Florence, Department of Experimental and Clinical Biomedical Sciences, Florence, Italy 12University of Bologna, Division of Gastroenterology and Internal Medicine, Sant'Orsola-Malpighi Hospital, Bologna, Italy 13University of Bologna, Pathology Unit, Sant'Orsola-Malpighi Hospital, Bologna, Italy 14Ca' Granda-Ospedale Maggiore Policlinico, Gastroenterology and Endoscopy Unit, Milan, Italy 15Ca' Granda-Ospedale Maggiore Policlinico, Division of Pathology, Milan, Italy 16Ospedale San Salvatore, L'Aquila, Italy 17Umberto I Hospital, Department of Radiological, Oncological and Pathological Sciences, Rome, Italy 18Ospedale V. Cervello, Palermo, Italy 19University of Salerno, Department of Medicine and Surgery, Salerno, Italy 20Federico II University of Naples, Department of Advanced Biomedical Sciences, Naples, Italy 21Spedali Civili di Brescia, Brescia, Italy 22Centro di Riferimento Oncologico, Aviano, Italy 23National Cancer Institute, Department of Pathology, Aviano, Italy 24University of Modena and Reggio Emilia, Section of Pathology, Modena, Italy 25Policlinico Tor Vergata, Roma, Italy 26San Camillo-Forlanini Hospital, Pathology Unit, Rome, Italy 27University of Pavia, Section of Oncology, Department of Onco-haematology, San Matteo Hospital, Pavia, Italy 28Sant'Eugenio Hospital, Clinical Nutrition Unit, Rome, Italy 29Istituto Superiore di Sanità, Unit of Nutrition and Health, Department of Veterinary Public Health and Food Safety, Rome, Italy 30University of Palermo, Institute of Pathologic Anatomy, Giaccone University Hospital, Palermo, Italy 31Azienda Ospedaliera San Filippo Neri, Roma, Italy 32University of Cagliari, Department of Internal Medicine, Cagliari, Italy 33SS. Trinità Hospital, Pathology Unit, Rome, Italy 34Città della Salute e della Scienza-Molinette Hospital, General and Specialistic Surgery, Turin, Italy 35Sant'Andrea Hospital, Unit of Pathological Anatomy, Vercelli, Italy 36University of Pavia, Department of Molecular Medicine, San Matteo Hospital, Pavia, Italy 37University of Pavia, First Department of Internal Medicine, San Matteo Hospital, Pavia, Italy

P302: Cytomegalovirus infection in pediatric acute severe ulcerative colitis – a multicenter case-controlled study from the Pediatric IBD Porto group of ESPGHANECCO '17 Barcelona
Year: 2017
Authors:

Cohen S.*1, Martinez-Vinson C.2, Aloi M.3, Turner D.4, Assa A.5, de Ridder L.6, Wolters V.M.7, de Meij T.8, Alvisi P.9, Bronsky J.10, Kopylov U.11

1“Dana-Dwek” Children's Hospital, Tel Aviv Sourasky Medical Center, The Pediatric Gastroenterology unit, Tel Aviv, Israel 2Hopital Robert Debré, Department of Gastroenterology and Nutrition, Paris, France 3Sapienza University of Rome, Pediatric Gastroenterology and liver unit, Rome, Italy 4Shaare Zedek Medical Center, Department of Paediatric Gastroenterology, Jerusalem, Israel 5Schneider Children's Medical Center, Department of Gastroenterology, Nutrition and Liver Diseases, Petach Tikvah, Israel 6Children's Hospital Erasmus MC Sophia, Department of Paediatric Gastroenterology, Rotterdam, Netherlands 7University Medical Center Utrecht, Department of Gastroenterology, Utrecht, Netherlands 8Vrije Universiteit Medical Center, Pediatric Gastroenterology, Amsterdam, Netherlands 9'Maggiore Hospital', GI Unit, Bologna, Italy 10University Hospital Motol, Department of Paediatrics, Prague 5, Czech Republic 11Sheba Medical Center, Department of Gastroenterology and Liver Diseases, Ramat Gan, Israel

P303: Gastrointestinal infectious agents detected by Biofire FilmArray GI PCR panel stool testing in active inflammatory bowel disease are common and associated with a more benign course of IBDECCO '17 Barcelona
Year: 2017
Authors:

Limsrivilai J.1,2, Stidham R.W.3, Govani S.3, Waljee A.3, Gutermuth B.3, Brown A.3, Briggs E.3, Rao K.4, Higgins P.D.*5

1Mahidol University, Bangkok, Thailand 2University of Michigan, Internal Medicine - Gastroenterology, Ann Arbor, Michigan, United States 3University of Michigan, Internal Medicine - Gastroenterology, Ann Arbor, United States 4University of Michigan, Internal Medicine - Infectious Diseases, Ann Arbor, United States 5University of Michigan, Internal Medicine - Gastroenterology, Ann Arbor, MI, United States

P304: Zinc levels, interplay with ATG16L1 and disease outcome in Crohn's disease patients in the Swiss IBD cohort studyECCO '17 Barcelona
Year: 2017
Authors:

Greuter T.*1, Franc Y.2, Kaelin M.3, Schoepfer A.4, Misselwitz B.1, Vavricka S.1,5, Rogler G.1, Biedermann L.1

1University Hospital Zurich, Division of Gastroenterology and Hepatology, Zurich, Switzerland 2University of Lausanne, Institute of Social and Preventive Medicine, Lausanne, Switzerland 3Unilabs Switzerland, Dübendorf, Switzerland 4University Hospital Lausanne - CHUV, Division of Gastroenterology and Hepatology, Lausanne, Switzerland 5Triemli Hospital Zurich, Division of Gastroenterology and Hepatology, Zurich, Switzerland

P305: Indirect comparison of two novel biologics for the treatment of Crohn's disease : network-meta analysis of ustekinumab vs vedolizumabECCO '17 Barcelona
Year: 2017
Authors:

Hather G.1, Curtis R.2, Minda K.2, Zouraq I.A.3, Khalid J.M.*4

1Takeda Development Center, Stats Innovation, Cambridge, United States 2Takeda Development Centre Europe Ltd, Global Medical Affairs, London, United Kingdom 3Takeda Pharmaceuticals International AG, Health Economics, Zürich, Switzerland 4Takeda Development Centre Europe Ltd, Evidence and Value Generation, London, United Kingdom

P306: What is the impact of perianal disease on anorectal function and quality of life of IBD patients? A prospective observational studyECCO '17 Barcelona
Year: 2017
Authors:

Litta F.*1, Scaldaferri F.2, Parello A.1, Zinicola T.2, Gasbarrini A.2, Ratto C.1

1Catholic University of the Sacred Heart, Proctology Unit, Rome, Italy 2Catholic University, Institute of Medical Pathology, Rome, Italy